Cleared for Takeoff: FAA to Allow Commercial Unmanned Aircraft Systems Operations Later this Year
Client Alert | 1 min read | 07.30.13
On July 19, the FAA issued a Restricted Category type certificate to two small, unmanned aircraft systems (UAS) that permits aerial surveillance in the Arctic, a significant development that will pave the way for commercial UAS operations later this year (previously discussed here and here). Previous military use of the approved UAS helped facilitate FAA's action, which comes as an encouraging sign for aerospace manufacturers seeking new markets as well as other industries anticipating the emergence of civilian UAS, including agriculture, oil and gas exploration, law enforcement, and security.
Contacts
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
